MET and lung carcinoma: Although MET has been found to associate with other RTKs (Jo et al, 2000; Engelman et al, 2007; Lai et al, 2009; Mueller et al, 2010), the underlying mechanisms and regulation of such association in lung cancer with MET amplification remain largely unclear.